Advances in COVID-19 mRNA vaccine development
E Fang, X Liu, M Li, Z Zhang, L Song, B Zhu… - Signal transduction and …, 2022 - nature.com
To date, the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has determined 399,600,607 cases and 5,757,562 …
syndrome coronavirus 2 (SARS-CoV-2) has determined 399,600,607 cases and 5,757,562 …
Covid‐19 vaccines and variants of concern: a review
I Hadj Hassine - Reviews in medical virology, 2022 - Wiley Online Library
Since the outbreak of coronavirus disease 2019 (Covid‐19) in December 2019, caused by
the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the number of …
the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the number of …
Nanodelivery of nucleic acids
There is growing need for a safe, efficient, specific and non-pathogenic means for delivery of
gene therapy materials. Nanomaterials for nucleic acid delivery offer an unprecedented …
gene therapy materials. Nanomaterials for nucleic acid delivery offer an unprecedented …
Analysis of BNT162b2‐and CVnCoV‐elicited sera and of convalescent sera toward SARS‐CoV‐2 viruses
S Hein, ML Herrlein, I Mhedhbi, D Bender, V Haberger… - Allergy, 2022 - Wiley Online Library
Summary Background The mRNA vaccine BNT162b2 (Comirnaty, BioNTech/Pfizer) and the
vaccine candidate CVnCoV (Curevac) each encode a stabilized spike protein of SARS …
vaccine candidate CVnCoV (Curevac) each encode a stabilized spike protein of SARS …
Progress in vaccine development for infectious diseases—a Keystone Symposia report
J Cable, BS Graham, RA Koup… - Annals of the New …, 2023 - Wiley Online Library
The COVID‐19 pandemic has taught us many things, among the most important of which is
that vaccines are one of the cornerstones of public health that help make modern longevity …
that vaccines are one of the cornerstones of public health that help make modern longevity …
Future prospects in mRNA vaccine development
LS Mbatha, J Akinyelu, F Maiyo… - Biomedical Materials, 2023 - iopscience.iop.org
The recent advancements in messenger ribonucleic acid (mRNA) vaccine development
have vastly enhanced their use as alternatives to conventional vaccines in the prevention of …
have vastly enhanced their use as alternatives to conventional vaccines in the prevention of …